Gallacher S J, Fenner J A, Fisher B M, Quin J D, Fraser W D, Logue F C, Cowan R A, Boyle I T, MacCuish A C
University Department of Medicine, Glasgow Royal Infirmary, UK.
Diabet Med. 1993 Mar;10(2):129-33. doi: 10.1111/j.1464-5491.1993.tb00029.x.
Measurement of bone density and turnover was assessed in 20 premenopausal females with Type 1 diabetes mellitus and 27 age-sex-matched controls. Measurement was made of spinal (L2-4) and neck of femur bone density by dual-energy X-ray absorptiometry. L2-4 density was significantly higher in the diabetic patients compared with controls (1.224 +/- 0.021 g cm-2 vs. 1.161 +/- 0.020 g cm-2: p = 0.016). No significant difference was noted between the groups in neck of femur density. Measurement of bone formation was assessed by serum alkaline phosphatase and bone resorption by fasting urinary hydroxyproline/creatinine ratio. Alkaline phosphatase was significantly higher in the diabetic patients (185 +/- 16 Ul-1 vs 135 +/- 10 Ul-1: p < 0.01) as was hydroxyproline/creatinine ratio (0.028 +/- 0.003 vs 0.017 +/- 0.002: p = 0.002). No significant correlation was found between L2-4 density and glycated haemoglobin, duration of diabetes or daily dose of insulin taken. These data suggest that osteopenia is not associated with Type 1 diabetes mellitus; however these patients do have evidence of increased bone turnover and may therefore be at risk of osteoporosis in later life, particularly after the menopause.
对20名绝经前1型糖尿病女性和27名年龄及性别匹配的对照者进行了骨密度和骨转换测量。采用双能X线吸收法测量腰椎(L2 - 4)和股骨颈骨密度。糖尿病患者的L2 - 4密度显著高于对照组(1.224±0.021 g/cm²对1.161±0.020 g/cm²:p = 0.016)。两组之间股骨颈密度无显著差异。通过血清碱性磷酸酶评估骨形成,通过空腹尿羟脯氨酸/肌酐比值评估骨吸收。糖尿病患者的碱性磷酸酶显著更高(185±16 U/L对135±10 U/L:p < 0.01),羟脯氨酸/肌酐比值也是如此(0.028±0.003对0.017±0.002:p = 0.002)。未发现L2 - 4密度与糖化血红蛋白、糖尿病病程或每日胰岛素剂量之间存在显著相关性。这些数据表明骨质减少与1型糖尿病无关;然而,这些患者确实有骨转换增加的证据,因此在晚年可能有患骨质疏松症的风险,尤其是在绝经后。